Engineered CRISPR–Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing
Benjamin P. Kleinstiver(Harvard University), J. Keith Joung(Massachusetts General Hospital), Kendell Clement(Broad Institute), Russell T. Walton(Massachusetts Institute of Technology), Irene Scarfò(Harvard University), Marcela V. Maus(Center for Cancer Research), Y. Esther Tak(Harvard University), Martin J. Aryee(Johns Hopkins University), Joy E. Horng(Massachusetts General Hospital), Jonathan Y. Hsu(Broad Institute), Jose Malagon-Lopez(GeneFluidics (United States)), Moira M. Welch(Massachusetts General Hospital), Luca Pinello(Broad Institute), Alexander A. Sousa(Broad Institute)
Cited by 724
Related Papers
High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
|Nature Biotechnology|2013|3.3k
CRISPR-Cas systems for editing, regulating and targeting genomes
|Nature Biotechnology|2014|3.2k
Efficient genome editing in zebrafish using a CRISPR-Cas system
|Nature Biotechnology|2013|3k
High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects
|Nature|2016|2.7k
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
|Nature Biotechnology|2014|2.3k